AVR — Anteris Technologies Global Corp.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 2011514 ·
Last close
$7.69
Market Cap
$749.46M
52W High
$11.06
52W Low
$3.30
ADV30
715,593
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,009,000 | 776,000 | -30,997,000 | -29,094,000 | 272,507,000 | 256,867,000 | 20,837,000 |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 310,000 | 219,000 | -29,207,000 | -29,202,000 | 22,997,000 | — | 23,250,000 |
| Sep 2025 | — | — | — | — | — | — | — |
Balance + Analyst (yfinance extras)
Retained Earnings
—
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,242,000
EBITDA
$-104,496,000
Free Cash Flow
$-51,131,624
Enterprise Value
$560,516,288
Total Cash
$256,867,008
Total Debt
$3,322,000
Shares Out
97,458,474
Trailing EPS
$-1.95
Book Value
$2.58
ROE
-74.7%
ROA
-42.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,913,000 | -94,136,000 | -94,144,000 | 22,997,000 | 23,250,000 | -93,000 | -77,803,000 |
| Dec 2024 | 2,703,000 | -77,329,000 | -76,291,000 | 80,699,000 | 18,017,000 | 62,761,000 | -61,241,000 |
| Dec 2023 | 2,800,884 | -48,122,276 | -45,874,304 | 31,136,343 | 11,608,797 | 19,486,580 | — |
| Dec 2022 | 3,122,608 | -32,236,540 | -30,164,606 | 15,973,036 | 6,980,985 | 8,992,051 | — |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.00
Max Pain — expiry 2026-11-20
max pain strike: $7.50 · spot: $7.61 · call oi: 1,788 · put oi: 2,345
Expected Move to 2026-11-20:
±$1.43
(18.73%) —
implied range
$6.19 –
$9.04
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INMD | InMode Ltd. | $820.58M | $14.26 | — |
| MDXG | MIMEDX GROUP, INC. | $681.51M | $4.67 | — |
| SIBN | SI-BONE, Inc. | $833.18M | $18.59 | — |
| ANGO | ANGIODYNAMICS INC | $640.24M | $15.49 | — |
| SGP | SpyGlass Pharma, Inc. | $905.44M | $27.07 | — |
News headlines (Yahoo Finance, 1h cache)
Anteris Technologies advances PARADIGM Trial in June quarter as US patient recruitment gets underway
2026-08-11 23:22 · Yahoo
Anteris Technologies Announces Results for the Second Quarter of 2026
2026-08-11 23:00 · Yahoo
Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors
2026-05-13 12:39 · Yahoo
Anteris Announces Results for the First Quarter of 2026
2026-05-12 23:00 · Yahoo
Anteris Technologies enrolls First US patients in global PARADIGM trial for DurAVR heart valve
2026-05-06 17:40 · Yahoo
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
2026-05-05 10:00 · Yahoo
Anteris adds Susan Knight, Stephen Denaro to board as company advances heart valve strategy
2026-05-13 01:33 · Yahoo
Anteris advances PARADIGM trial as Q1 cash burn reflects commercialisation push
2026-05-12 23:43 · Yahoo
Anteris treats first US patients in DurAVR pivotal trial
2026-05-07 01:45 · Yahoo
Anteris Technologies appoints Brent Moen as chief financial officer
2026-09-06 23:47 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.